BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 15850680)

  • 1. Otorhinolaryngological manifestations of the mucopolysaccharidoses.
    Simmons MA; Bruce IA; Penney S; Wraith E; Rothera MP
    Int J Pediatr Otorhinolaryngol; 2005 May; 69(5):589-95. PubMed ID: 15850680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway.
    Gönüldaş B; Yılmaz T; Sivri HS; Güçer KŞ; Kılınç K; Genç GA; Kılıç M; Coşkun T
    Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):944-9. PubMed ID: 24731921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hearing loss and airway problems in children with mucopolysaccharidoses].
    Santos S; López L; González L; Domínguez MJ
    Acta Otorrinolaringol Esp; 2011; 62(6):411-7. PubMed ID: 21757178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENT and mucopolysaccharidoses.
    Bianchi PM; Gaini R; Vitale S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):127. PubMed ID: 30442170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory manifestations in mucopolysaccharidoses.
    Muhlebach MS; Wooten W; Muenzer J
    Paediatr Respir Rev; 2011 Jun; 12(2):133-8. PubMed ID: 21458742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review.
    Ruckenstein MJ; Macdonald RE; Clarke JT; Forte V
    J Otolaryngol; 1991 Jun; 20(3):177-83. PubMed ID: 1908026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses.
    Lee CL; Lee KS; Chuang CK; Su CH; Chiu HC; Tu RY; Lo YT; Chang YH; Lin HY; Lin SP
    Int J Med Sci; 2021; 18(15):3373-3379. PubMed ID: 34522163
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience.
    Mesolella M; Cimmino M; Cantone E; Marino A; Cozzolino M; Della Casa R; Parenti G; Iengo M
    Acta Otorhinolaryngol Ital; 2013 Aug; 33(4):267-72. PubMed ID: 24043915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musculoskeletal manifestations of mucopolysaccharidoses.
    Morishita K; Petty RE
    Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v19-25. PubMed ID: 22210666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.
    Murgasova L; Jurovcik M; Jesina P; Malinova V; Bloomfield M; Zeman J; Magner M
    Int J Pediatr Otorhinolaryngol; 2020 Aug; 135():110137. PubMed ID: 32502916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The otologic manifestations of mucopolysaccharidoses.
    Hayes E; Babin R; Platz C
    Am J Otol; 1980 Oct; 2(2):65-9. PubMed ID: 6782888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoids of patients with mucopolysaccharidoses demonstrate typical alterations.
    Keilmann A; Läßig AK; Pollak-Hainz A; Mann WJ; Beck M; Hainz M
    Int J Pediatr Otorhinolaryngol; 2015 Feb; 79(2):115-8. PubMed ID: 25487873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mucopolysaccharidoses--biochemical mechanisms of diseases and therapeutic possibilities].
    Kloska A; Tylki-Szymańska A; Wegrzyn G
    Postepy Biochem; 2011; 57(2):133-47. PubMed ID: 21913414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurologic manifestations in mucopolysaccharidoses].
    Héron B
    Arch Pediatr; 2014 Jun; 21 Suppl 1():S14-21. PubMed ID: 25063379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidoses: anesthetic considerations and clinical manifestations.
    Sam JA; Baluch AR; Niaz RS; Lonadier L; Kaye AD
    Middle East J Anaesthesiol; 2011 Jun; 21(2):243-50. PubMed ID: 22435276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Upper airway obstruction in a child caused by enlarged tonsils and adenoids].
    Lacroix J; Weber ML
    Can Med Assoc J; 1980 Jan; 122(2):196-8. PubMed ID: 7363215
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic cor pulmonale in childhood caused by upper airway obstruction by tonsillar and adenoid hypertrophy].
    Frossi V; Devincenzo C; Quattrociocchi M; Contini E; Deluca L; Tessitore E; Montella S
    Minerva Pediatr; 1981 May; 33(9):429-34. PubMed ID: 7254162
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mucopolysaccharidoses and their manifestations of otorhinolaryngiatric interest].
    Borasi F; Pallestrini EA
    Ann Laringol Otol Rinol Faringol; 1978; 76(3):305-20. PubMed ID: 121953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.